|
1
|
Folkman J: Angiogenesis: an organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Potente M, Gerhardt H and Carmeliet P:
Basic and therapeutic aspects of angiogenesis. Cell. 146:873–887.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang WG, Martin TA, Parr C, Davies G,
Matsumoto K and Nakamura T: Hepatocyte growth factor, its receptor,
and their potential value in cancer therapies. Crit Rev Oncol
Hematol. 53:35–69. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wojta J, Kaun C, Breuss JM, et al:
Hepatocyte growth factor increases expression of vascular
endothelial growth factor and plasminogen activator inhibitor-1 in
human keratinocytes and the vascular endothelial growth factor
receptor flk-1 in human endothelial cells. Lab Invest. 79:427–438.
1999.
|
|
5
|
Davies G, Mason MD, Martin TA, et al: The
HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate
tumor growth and angiogenesis in vivo. Int J Cancer. 106:348–354.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martin TA, Parr C, Davies G, et al: Growth
and angiogenesis of human breast cancer in a nude mouse tumour
model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis.
24:1317–1323. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Monnier PP, Sierra A, Macchi P, et al: RGM
is a repulsive guidance molecule for retinal axons. Nature.
419:392–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oldekamp J, Kramer N, Alvarez-Bolado G and
Skutella T: Expression pattern of the repulsive guidance molecules
RGM A, B and C during mouse development. Gene Expr Patterns.
4:283–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmidtmer J and Engelkamp D: Isolation
and expression pattern of three mouse homologues of chick Rgm. Gene
Expr Patterns. 4:105–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niederkofler V, Salie R, Sigrist M and
Arber S: Repulsive guidance molecule (RGM) gene function is
required for neural tube closure but not retinal topography in the
mouse visual system. J Neurosci. 24:808–818. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Samad TA, Srinivasan A, Karchewski LA, et
al: DRAGON: a member of the repulsive guidance molecule-related
family of neuronal- and muscle-expressed membrane proteins is
regulated by DRG11 and has neuronal adhesive properties. J
Neurosci. 24:2027–2036. 2004. View Article : Google Scholar
|
|
12
|
Ma CH, Brenner GJ, Omura T, et al: The BMP
coreceptor RGMb promotes while the endogenous BMP antagonist noggin
reduces neurite outgrowth and peripheral nerve regeneration by
modulating BMP signaling. J Neurosci. 31:18391–18400. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, Hashimoto M, Horii H, Yamaguchi A,
Naito K and Yamashita T: Repulsive guidance molecule b inhibits
neurite growth and is increased after spinal cord injury. Biochem
Biophys Res Commun. 382:795–800. 2009. View Article : Google Scholar
|
|
14
|
Samad TA, Rebbapragada A, Bell E, et al:
DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem.
280:14122–14129. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Babitt JL, Zhang Y, Samad TA, et al:
Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone
morphogenetic protein co-receptor. J Biol Chem. 280:29820–29827.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Babitt JL, Huang FW, Wrighting DM, et al:
Bone morphogenetic protein signaling by hemojuvelin regulates
hepcidin expression. Nat Genet. 38:531–539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Halbrooks PJ, Ding R, Wozney JM and Bain
G: Role of RGM coreceptors in bone morphogenetic protein signaling.
J Mol Signal. 2:42007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia Y, Sidis Y, Mukherjee A, et al:
Localization and action of Dragon (repulsive guidance molecule b),
a novel bone morphogenetic protein coreceptor, throughout the
reproductive axis. Endocrinology. 146:3614–3621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia Y, Cortez-Retamozo V, Niederkofler V,
et al: Dragon (repulsive guidance molecule b) inhibits IL-6
expression in macrophages. J Immunol. 186:1369–1376. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Ye L, Mansel RE and Jiang WG:
Potential prognostic value of repulsive guidance molecules in
breast cancer. Anticancer Res. 31:1703–1711. 2011.PubMed/NCBI
|
|
21
|
Li J, Ye L, Kynaston HG and Jiang WG:
Repulsive guidance molecules, novel bone morphogenetic protein
co-receptors, are key regulators of the growth and aggressiveness
of prostate cancer cells. Int J Oncol. 40:544–550. 2012.PubMed/NCBI
|
|
22
|
Li J, Ye L, Sanders AJ and Jiang WG:
Repulsive guidance molecule B (RGMB) plays negative roles in breast
cancer by coordinating BMP signaling. J Cell Biochem.
113:2523–2531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sanders AJ, Parr C, Mason MD and Jiang WG:
Suppression of hepatocyte growth factor activator inhibitor-1 leads
to a more aggressive phenotype of prostate cancer cells in
vitro. Int J Mol Med. 20:613–619. 2007.
|
|
24
|
Yuan Z, Sanders AJ, Ye L, Wang Y and Jiang
WG: Knockdown of human antigen R reduces the growth and invasion of
breast cancer cells in vitro and affects expression of
cyclin D1 and MMP-9. Oncol Rep. 26:237–245. 2011.PubMed/NCBI
|
|
25
|
Zuker M: Mfold web server for nucleic acid
folding and hybridization prediction. Nucleic Acids Res.
31:3406–3415. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parr C, Sanders AJ, Davies G, et al:
Matriptase-2 inhibits breast tumor growth and invasion and
correlates with favorable prognosis for breast cancer patients.
Clin Cancer Res. 13:3568–3576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parr C, Watkins G, Mansel RE and Jiang WG:
The hepatocyte growth factor regulatory factors in human breast
cancer. Clin Cancer Res. 10:202–211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang WG, Hiscox SE, Parr C, et al:
Antagonistic effect of NK4, a novel hepatocyte growth factor
variant, on in vitro angiogenesis of human vascular endothelial
cells. Clin Cancer Res. 5:3695–3703. 1999.
|
|
29
|
Sanders AJ, Ye L, Mason MD and Jiang WG:
The impact of EPLINalpha (Epithelial protein lost in neoplasm) on
endothelial cells, angiogenesis and tumorigenesis. Angiogenesis.
13:317–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
David L, Feige JJ and Bailly S: Emerging
role of bone morphogenetic proteins in angiogenesis. Cytokine
Growth Factor Rev. 20:203–212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cai J, Pardali E, Sanchez-Duffhues G and
ten Dijke P: BMP signaling in vascular diseases. FEBS Lett.
586:1993–2002. 2012. View Article : Google Scholar
|
|
32
|
Ye L, Lewis-Russell JM, Davies G, Sanders
AJ, Kynaston H and Jiang WG: Hepatocyte growth factor up-regulates
the expression of the bone morphogenetic protein (BMP) receptors,
BMPR-IB and BMPR-II, in human prostate cancer cells. Int J Oncol.
30:521–529. 2007.PubMed/NCBI
|
|
33
|
Ye L, Lewis-Russell JM, Sanders AJ,
Kynaston H and Jiang WG: HGF/SF up-regulates the expression of bone
morphogenetic protein 7 in prostate cancer cells. Urol Oncol.
26:190–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kanomata K, Kokabu S, Nojima J, Fukuda T
and Katagiri T: DRAGON, a GPI-anchored membrane protein, inhibits
BMP signaling in C2C12 myoblasts. Genes Cells. 14:695–702. 2009.
View Article : Google Scholar : PubMed/NCBI
|
